NCT00442897
Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)
See it on ClinicalTrials.gov ↗229 people
48%
52%
110 womenmiddle line = equal numbers119 men
- Phase
- PHASE4
- Paid for by
- Organon and Co
- Finished
- 2008-10
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 61.30 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 24.92 Kg/m2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant women”
Study titles and rules are shown in their original English.